Rituxan

Active Ingredient(s): Rituximab
FDA Approved: * November 26, 1997
Pharm Company: * GENENTECH
Category: Cancer

Rituximab, sold under the brand name Rituxan among others, is a monoclonal antibody medication used to treat certain autoimmune diseases and types of cancer.[9] It is used for non-Hodgkin lymphoma, chronic lymphocytic leukemia (in non-geriatric patients), rheumatoid arthritis, granulomatosis with polyangiitis, idiopathic thrombocytopenic purpura, pemphigus vulgaris, myasthenia gravis and Epstein–Barr virus-positive mucocutaneous ulcers.[9][10&... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.

Dosage List

Rituxan 10 mg/ml Intravenous Injection, Solution
NDC: 50242-051
Labeler:
Genentech, Inc.
Rituxan 10 mg/ml Intravenous Injection, Solution
NDC: 50242-053
Labeler:
Genentech, Inc.

Related Brands

Drugs with the same active ingredients